Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Added: 2 months ago Source:  Radcliffe Cardiology
For patients hospitalised with acute heart failure, receiving an influenza vaccination prior to discharge can significantly lower the risk of all-cause mortality and subsequent hospital readmission over the following year. These findings come from the PANDA II trial, a large cluster-randomised study conducted in China.¹PANDA II was a pragmatic, multiregional, parallel-group, cluster-randomised,… View more
Added: 3 months ago Source:  Radcliffe Cardiology
A large-scale, nationwide study from South Korea suggests that vaccination with the live zoster vaccine is associated with a significantly lower risk of various cardiovascular (CV) events in adults aged 50 and older. The findings indicate a protective association that persists for up to 8 years post-vaccination.¹This population-based cohort study analysed data from over 2.2 million individuals… View more
Author(s): Harriette Van Spall , Tor Biering-Sørensen Added: 12 months ago
AHA Conference 2024 — New insights from the NUDGE-FLU Program on electronic nudges to increase influenza vaccination amongst patients with a history of myocardial infarction.Dr Harriette Van Spall (McMaster University, CA) sits down with the principal investigator of the NUDGE-FLU trial, (NCT05542004) Dr Tor Biering-Sørensen, to discuss the latest insights and data.NUDGE-FLU is a prospective,… View more
Research Area(s) / Expertise: Job title: Associate Professor of Medicine
Dr Orly Vardeny is Associate Professor of Medicine at the University of Minnesota in Minneapolis. Her research interests include maximising the benefit of pharmacologic therapy in patients with heart failure and optimising vaccination strategies in patients with cardiac disorders. She has led several multi-center, randomized clinical trials evaluating influenza vaccines in patients with high-risk… View more
Added: 4 months ago Source:  ESC Congress 2025 Scientific Programme
ESC Congress 2025 has released twenty-eight late-breaking trials and science sessions to be presented in August 2025.The congress is set to take place from the 29th August to 1st September at IFEMA - Fiera de Madrid.Access the full programme here.Late-Breaking Clinical Science: Inflammation and Immune Biomarkers in Cardiovascular Risk PredictionFriday 29th August, 08:15am – 09:45am (CEST… View more
Research Area(s) / Expertise:

Cardio-oncology

Job title: Head of the Medical Support Team, Jules Bordet Insitute, Brussels, Belgium
Evandro de Azambuja, MD, PhD, leads the Medical Support Team (Academic Promoting Team) at the Jules Bordet Institute in Brussels, Belgium. In this role, he oversees 4-5 research fellows and provides medical supervision for large phase III clinical trials, particularly in breast cancer.Dr. de Azambuja holds two PhDs, one from the Federal University of Rio Grande do Sul, Porto Alegre, Brazil, in… View more